Artemether–lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study

BACKGROUND: Ethiopia has set a goal to eliminate malaria by 2030; Artemether–lumefantrine (AL) is put as one of the cornerstone strategies for uncomplicated plasmodium falciparum malaria treatment. However, only focusing on prescribing of the treatment without assessing patients’ adherence could lea...

詳細記述

保存先:
書誌詳細
出版年:Antimicrob Resist Infect Control
主要な著者: Gebrekidan, Mekonnen Gebremichael, Gebremedhin, Gebretsadik Berhe, Gebregiorgis, Yosef Sibhatu, Gezehegn, Alefech Addisu, Weldearegay, Kissanet Tesfay
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7653737/
https://ncbi.nlm.nih.gov/pubmed/33168093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13756-020-00846-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料